Viimased lisandused - Macular Diseases - Acquired
|
Elmiron (pentasosan polysulfate) Macular Toxicityvaatamisi: 11777 year old female who had been on Elmiron for 20 years and stopped it 2 years agomärts 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvaatamisi: 9677 year old female who had been on Elmiron for 20 years and stopped it 2 years agomärts 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvaatamisi: 10177 year old female who had been on Elmiron for 20 years and stopped it 2 years agomärts 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvaatamisi: 4877 year old female who had been on Elmiron for 20 years and stopped it 2 years agomärts 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvaatamisi: 4977 year old female who had been on Elmiron for 20 years and stopped it 2 years agomärts 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvaatamisi: 5677 year old female who had been on Elmiron for 20 years and stopped it 2 years agomärts 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvaatamisi: 6277 year old female who had been on Elmiron for 20 years and stopped it 2 years agomärts 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvaatamisi: 5877 year old female who had been on Elmiron for 20 years and stopped it 2 years agomärts 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvaatamisi: 4777 year old female who had been on Elmiron for 20 years and stopped it 2 years agomärts 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvaatamisi: 5277 year old female who had been on Elmiron for 20 years and stopped it 2 years agomärts 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvaatamisi: 5177 year old female who had been on Elmiron for 20 years and stopped it 2 years agomärts 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvaatamisi: 5577 year old female who had been on Elmiron for 20 years and stopped it 2 years agomärts 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvaatamisi: 5577 year old female who had been on Elmiron for 20 years and stopped it 2 years agomärts 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvaatamisi: 5877 year old female who had been on Elmiron for 20 years and stopped it 2 years agomärts 15, 2026
|
|
MacTel with foveal atrophy in both eyesvaatamisi: 4462 year old female with 20/50 OD, 20/40 OS.veebr 18, 2026
|
|
MacTel with foveal atrophy in both eyesvaatamisi: 4262 year old female with 20/50 OD, 20/40 OS.veebr 18, 2026
|
|
MacTel with foveal atrophy in both eyesvaatamisi: 3862 year old female with 20/50 OD, 20/40 OS.veebr 18, 2026
|
|
MacTel with foveal atrophy in both eyesvaatamisi: 4262 year old female with 20/50 OD, 20/40 OS.veebr 18, 2026
|
|
MacTel with foveal atrophy in both eyesvaatamisi: 4562 year old female with 20/50 OD, 20/40 OS.veebr 18, 2026
|
|
MacTel with foveal atrophy in both eyesvaatamisi: 4462 year old female with 20/50 OD, 20/40 OS.veebr 18, 2026
|
|
MacTel with foveal atrophy in both eyesvaatamisi: 4462 year old female with 20/50 OD, 20/40 OS.veebr 18, 2026
|
|
MacTel with foveal atrophy in both eyesvaatamisi: 4462 year old female with 20/50 OD, 20/40 OS.veebr 18, 2026
|
|
MacTel with foveal atrophy in both eyesvaatamisi: 4562 year old female with 20/50 OD, 20/40 OS.veebr 18, 2026
|
|
MacTel with foveal atrophy in both eyesvaatamisi: 4562 year old female with 20/50 OD, 20/40 OS.veebr 18, 2026
|
|
MacTel with foveal atrophy in both eyesvaatamisi: 4662 year old female with 20/50 OD, 20/40 OS.veebr 18, 2026
|
|
MacTel with foveal atrophy in both eyesvaatamisi: 4462 year old female with 20/50 OD, 20/40 OS.veebr 18, 2026
|
|
MacTel with foveal atrophy in both eyesvaatamisi: 5262 year old female with 20/50 OD, 20/40 OS.veebr 18, 2026
|
|
MacTel with foveal atrophy in both eyesvaatamisi: 4162 year old female with 20/50 OD, 20/40 OS.veebr 18, 2026
|
|
MacTel with foveal atrophy in both eyesvaatamisi: 5162 year old female with 20/50 OD, 20/40 OS.veebr 18, 2026
|
|
Latanoprost induced CMEvaatamisi: 5989 year old man with CME from latanoprost that cleared within one month of stopping the medicationnov 23, 2025
|
|
Latanoprost induced CMEvaatamisi: 7289 year old man with CME from latanoprost that cleared within one month of stopping the medicationnov 23, 2025
|
|
Latanoprost induced CMEvaatamisi: 6489 year old man with CME from latanoprost that cleared within one month of stopping the medicationnov 23, 2025
|
|
Latanoprost induced CMEvaatamisi: 5889 year old man with CME from latanoprost that cleared within one month of stopping the medicationnov 23, 2025
|
|
Latanoprost induced CMEvaatamisi: 6689 year old man with CME from latanoprost that cleared within one month of stopping the medicationnov 23, 2025
|
|
Latanoprost induced CMEvaatamisi: 6989 year old man with CME from latanoprost that cleared within one month of stopping the medicationnov 23, 2025
|
|
Latanoprost induced CMEvaatamisi: 6289 year old man with CME from latanoprost that cleared within one month of stopping the medicationnov 23, 2025
|
|
Latanoprost induced CMEvaatamisi: 8389 year old man with CME from latanoprost that cleared within one month of stopping the medicationnov 23, 2025
|
|
Latanoprost induced CMEvaatamisi: 5889 year old man with CME from latanoprost that cleared within one month of stopping the medicationnov 23, 2025
|
|
Latanoprost induced CMEvaatamisi: 5789 year old man with CME from latanoprost that cleared within one month of stopping the medicationnov 23, 2025
|
|
Latanoprost induced CMEvaatamisi: 6689 year old man with CME from latanoprost that cleared within one month of stopping the medicationnov 23, 2025
|
|
Latanoprost induced CMEvaatamisi: 7389 year old man with CME from latanoprost that cleared within one month of stopping the medicationnov 23, 2025
|
|
Latanoprost induced CMEvaatamisi: 6889 year old man with CME from latanoprost that cleared within one month of stopping the medicationnov 23, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 8574 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 8074 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 7574 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 7674 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 7274 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 7674 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 7574 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 6274 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 7274 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 6574 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 7874 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 6474 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 9174 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 6774 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 7374 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 5874 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvaatamisi: 7874 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15aug 17, 2025
|
|
Hydroxychloroquine Toxicityvaatamisi: 10560 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSdets 22, 2024
|
|
Hydroxychloroquine Toxicityvaatamisi: 12860 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSdets 22, 2024
|
|
Hydroxychloroquine Toxicityvaatamisi: 12660 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSdets 22, 2024
|
|
Hydroxychloroquine Toxicityvaatamisi: 12860 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSdets 22, 2024
|
|
Hydroxychloroquine Toxicityvaatamisi: 11560 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSdets 22, 2024
|
|
Hydroxychloroquine Toxicityvaatamisi: 10860 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSdets 22, 2024
|
|
Hydroxychloroquine Toxicityvaatamisi: 10360 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSdets 22, 2024
|
|
Hydroxychloroquine Toxicityvaatamisi: 13660 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSdets 22, 2024
|
|
Hydroxychloroquine Toxicityvaatamisi: 14660 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSdets 22, 2024
|
|
Hydroxychloroquine Toxicityvaatamisi: 11060 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSdets 22, 2024
|
|
Pseudophakic CME chronicvaatamisi: 9674 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timololnov 06, 2024
|
|
Pseudophakic CME chronicvaatamisi: 9974 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timololnov 06, 2024
|
|
Pseudophakic CME chronicvaatamisi: 11674 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timololnov 06, 2024
|
|
Pseudophakic CME chronicvaatamisi: 12474 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timololnov 06, 2024
|
|
Pseudophakic CME chronicvaatamisi: 11674 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timololnov 06, 2024
|
|
Pseudophakic CME chronicvaatamisi: 10974 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timololnov 06, 2024
|
|
Pseudophakic CME chronicvaatamisi: 11874 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timololnov 06, 2024
|
|
Pseudophakic CME chronicvaatamisi: 11774 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timololnov 06, 2024
|
|
Pseudophakic CME chronicvaatamisi: 10174 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timololnov 06, 2024
|
|
Pseudophakic CME chronicvaatamisi: 10174 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timololnov 06, 2024
|
|
Pseudophakic CME chronicvaatamisi: 11974 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timololnov 06, 2024
|
|
Pseudophakic CME chronicvaatamisi: 10774 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timololnov 06, 2024
|
|
Pseudophakic CME chronicvaatamisi: 10074 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timololnov 06, 2024
|
|
Pseudophakic CME chronicvaatamisi: 10274 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timololnov 06, 2024
|
|
Pseudophakic CME chronicvaatamisi: 12774 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timololnov 06, 2024
|
|
Pseudophakic CME chronicvaatamisi: 10074 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timololnov 06, 2024
|
|
Pseudophakic CME chronicvaatamisi: 10074 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timololnov 06, 2024
|
|
Pseudophakic CME chronicvaatamisi: 10774 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timololnov 06, 2024
|
|
Pseudophakic CME chronicvaatamisi: 12474 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timololnov 06, 2024
|
|
Pseudophakic CME chronicvaatamisi: 13774 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timololnov 06, 2024
|
|
Pseudophakic CME chronicvaatamisi: 11374 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timololnov 06, 2024
|
|
Pseudophakic CME chronicvaatamisi: 10674 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timololnov 06, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevaatamisi: 12060 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSsept 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevaatamisi: 11560 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSsept 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevaatamisi: 11960 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSsept 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevaatamisi: 11460 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSsept 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevaatamisi: 9660 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSsept 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevaatamisi: 9760 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSsept 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevaatamisi: 9060 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSsept 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevaatamisi: 11260 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSsept 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevaatamisi: 9660 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSsept 17, 2024
|
|
|
|
